img

Global Hereditary Angioedema Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hereditary Angioedema Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

In the past 2 years, the FDA has approved 3 new drugs for prevention or treatment of hereditary angioedema (HAE) in non-pregnant adolescents and adultsthe C1 esterase inhibitor Cinryze for prophylaxis and the C1 esterase inhibitor Berinert and the kallikrein inhibitor ecallantide (Kalbitor) for treatment of acute attacks.
Hereditary Angioedema Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hereditary Angioedema Drug market is projected to reach US$ 1145.6 million in 2029, increasing from US$ 743 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029. Demand from Retail Pharmacies and Hospital Pharmacies are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hereditary Angioedema Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pharming Group NV
Takeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Segment by Type
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist

Segment by Application


Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hereditary Angioedema Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hereditary Angioedema Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hereditary Angioedema Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hereditary Angioedema Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hereditary Angioedema Drug introduction, etc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Hereditary Angioedema Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Hereditary Angioedema Drug Market Overview
1.1 Hereditary Angioedema Drug Product Overview
1.2 Hereditary Angioedema Drug Market Segment by Type
1.2.1 C1 Esterase Inhibitor
1.2.2 Kallikrein Inhibitor
1.2.3 Selective Bradykinin B2 Receptor Antagonist
1.3 Global Hereditary Angioedema Drug Market Size by Type
1.3.1 Global Hereditary Angioedema Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Hereditary Angioedema Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Hereditary Angioedema Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hereditary Angioedema Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Hereditary Angioedema Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Hereditary Angioedema Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Hereditary Angioedema Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Hereditary Angioedema Drug Sales Breakdown by Type (2018-2024)
2 Global Hereditary Angioedema Drug Market Competition by Company
2.1 Global Top Players by Hereditary Angioedema Drug Sales (2018-2024)
2.2 Global Top Players by Hereditary Angioedema Drug Revenue (2018-2024)
2.3 Global Top Players by Hereditary Angioedema Drug Price (2018-2024)
2.4 Global Top Manufacturers Hereditary Angioedema Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hereditary Angioedema Drug Market Competitive Situation and Trends
2.5.1 Hereditary Angioedema Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Hereditary Angioedema Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Hereditary Angioedema Drug Market
2.8 Key Manufacturers Hereditary Angioedema Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hereditary Angioedema Drug Status and Outlook by Region
3.1 Global Hereditary Angioedema Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hereditary Angioedema Drug Historic Market Size by Region
3.2.1 Global Hereditary Angioedema Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Hereditary Angioedema Drug Sales in Value by Region (2018-2024)
3.2.3 Global Hereditary Angioedema Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Hereditary Angioedema Drug Forecasted Market Size by Region
3.3.1 Global Hereditary Angioedema Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Hereditary Angioedema Drug Sales in Value by Region (2024-2029)
3.3.3 Global Hereditary Angioedema Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hereditary Angioedema Drug by Application
4.1 Hereditary Angioedema Drug Market Segment by Application
4.1.1 Retail Pharmacies
4.1.2 Hospital Pharmacies
4.1.3 Online Pharmacies
4.2 Global Hereditary Angioedema Drug Market Size by Application
4.2.1 Global Hereditary Angioedema Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Hereditary Angioedema Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Hereditary Angioedema Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hereditary Angioedema Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Hereditary Angioedema Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Hereditary Angioedema Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Hereditary Angioedema Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Hereditary Angioedema Drug Sales Breakdown by Application (2018-2024)
5 North America Hereditary Angioedema Drug by Country
5.1 North America Hereditary Angioedema Drug Historic Market Size by Country
5.1.1 North America Hereditary Angioedema Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hereditary Angioedema Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Hereditary Angioedema Drug Sales in Value by Country (2018-2024)
5.2 North America Hereditary Angioedema Drug Forecasted Market Size by Country
5.2.1 North America Hereditary Angioedema Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Hereditary Angioedema Drug Sales in Value by Country (2024-2029)
6 Europe Hereditary Angioedema Drug by Country
6.1 Europe Hereditary Angioedema Drug Historic Market Size by Country
6.1.1 Europe Hereditary Angioedema Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hereditary Angioedema Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Hereditary Angioedema Drug Sales in Value by Country (2018-2024)
6.2 Europe Hereditary Angioedema Drug Forecasted Market Size by Country
6.2.1 Europe Hereditary Angioedema Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Hereditary Angioedema Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Hereditary Angioedema Drug by Region
7.1 Asia-Pacific Hereditary Angioedema Drug Historic Market Size by Region
7.1.1 Asia-Pacific Hereditary Angioedema Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hereditary Angioedema Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Hereditary Angioedema Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Hereditary Angioedema Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Hereditary Angioedema Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hereditary Angioedema Drug Sales in Value by Region (2024-2029)
8 Latin America Hereditary Angioedema Drug by Country
8.1 Latin America Hereditary Angioedema Drug Historic Market Size by Country
8.1.1 Latin America Hereditary Angioedema Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hereditary Angioedema Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Hereditary Angioedema Drug Sales in Value by Country (2018-2024)
8.2 Latin America Hereditary Angioedema Drug Forecasted Market Size by Country
8.2.1 Latin America Hereditary Angioedema Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hereditary Angioedema Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Hereditary Angioedema Drug by Country
9.1 Middle East and Africa Hereditary Angioedema Drug Historic Market Size by Country
9.1.1 Middle East and Africa Hereditary Angioedema Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hereditary Angioedema Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Hereditary Angioedema Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Hereditary Angioedema Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Hereditary Angioedema Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hereditary Angioedema Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pharming Group NV
10.1.1 Pharming Group NV Company Information
10.1.2 Pharming Group NV Introduction and Business Overview
10.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pharming Group NV Hereditary Angioedema Drug Products Offered
10.1.5 Pharming Group NV Recent Development
10.2 Takeda
10.2.1 Takeda Company Information
10.2.2 Takeda Introduction and Business Overview
10.2.3 Takeda Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Takeda Hereditary Angioedema Drug Products Offered
10.2.5 Takeda Recent Development
10.3 CSL Limited
10.3.1 CSL Limited Company Information
10.3.2 CSL Limited Introduction and Business Overview
10.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 CSL Limited Hereditary Angioedema Drug Products Offered
10.3.5 CSL Limited Recent Development
10.4 IBio Inc.
10.4.1 IBio Inc. Company Information
10.4.2 IBio Inc. Introduction and Business Overview
10.4.3 IBio Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 IBio Inc. Hereditary Angioedema Drug Products Offered
10.4.5 IBio Inc. Recent Development
10.5 BioCryst Pharmaceuticals, Inc.
10.5.1 BioCryst Pharmaceuticals, Inc. Company Information
10.5.2 BioCryst Pharmaceuticals, Inc. Introduction and Business Overview
10.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Products Offered
10.5.5 BioCryst Pharmaceuticals, Inc. Recent Development
10.6 Ionis Pharmaceuticals, Inc.
10.6.1 Ionis Pharmaceuticals, Inc. Company Information
10.6.2 Ionis Pharmaceuticals, Inc. Introduction and Business Overview
10.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Products Offered
10.6.5 Ionis Pharmaceuticals, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hereditary Angioedema Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hereditary Angioedema Drug Industrial Chain Analysis
11.4 Hereditary Angioedema Drug Market Dynamics
11.4.1 Hereditary Angioedema Drug Industry Trends
11.4.2 Hereditary Angioedema Drug Market Drivers
11.4.3 Hereditary Angioedema Drug Market Challenges
11.4.4 Hereditary Angioedema Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hereditary Angioedema Drug Distributors
12.3 Hereditary Angioedema Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of C1 Esterase Inhibitor
Table 2. Major Company of Kallikrein Inhibitor
Table 3. Major Company of Selective Bradykinin B2 Receptor Antagonist
Table 4. Global Hereditary Angioedema Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Hereditary Angioedema Drug Sales by Type (2018-2024) & (K Units)
Table 6. Global Hereditary Angioedema Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Hereditary Angioedema Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Hereditary Angioedema Drug Market Share in Value by Type (2018-2024)
Table 9. Global Hereditary Angioedema Drug Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Hereditary Angioedema Drug Sales by Type (2024-2029) & (K Units)
Table 11. Global Hereditary Angioedema Drug Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Hereditary Angioedema Drug Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Hereditary Angioedema Drug Sales Market Share in Value by Type (2024-2029)
Table 14. Global Hereditary Angioedema Drug Price by Type (2024-2029) & (USD/Unit)
Table 15. North America Hereditary Angioedema Drug Sales by Type (2018-2024) & (K Units)
Table 16. North America Hereditary Angioedema Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Hereditary Angioedema Drug Sales (K Units) by Type (2018-2024)
Table 18. Europe Hereditary Angioedema Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Hereditary Angioedema Drug Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Hereditary Angioedema Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Hereditary Angioedema Drug Sales (K Units) by Type (2018-2024)
Table 22. Latin America Hereditary Angioedema Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Hereditary Angioedema Drug Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Hereditary Angioedema Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Hereditary Angioedema Drug Sales by Company (2018-2024) & (K Units)
Table 26. Global Hereditary Angioedema Drug Sales Share by Company (2018-2024)
Table 27. Global Hereditary Angioedema Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Hereditary Angioedema Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Hereditary Angioedema Drug Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Hereditary Angioedema Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Hereditary Angioedema Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Hereditary Angioedema Drug Market
Table 34. Key Manufacturers Hereditary Angioedema Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Hereditary Angioedema Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Hereditary Angioedema Drug Sales by Region (2018-2024) & (K Units)
Table 38. Global Hereditary Angioedema Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Hereditary Angioedema Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Hereditary Angioedema Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Hereditary Angioedema Drug Sales by Region (2024-2029) & (K Units)
Table 43. Global Hereditary Angioedema Drug Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Hereditary Angioedema Drug Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Hereditary Angioedema Drug Sales Market Share in Value by Region (2024-2029)
Table 46. Global Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 47. Global Hereditary Angioedema Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Hereditary Angioedema Drug Sales by Application (2018-2024) & (K Units)
Table 49. Global Hereditary Angioedema Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Hereditary Angioedema Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Hereditary Angioedema Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Hereditary Angioedema Drug Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Hereditary Angioedema Drug Sales by Application (2024-2029) & (K Units)
Table 54. Global Hereditary Angioedema Drug Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Hereditary Angioedema Drug Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Hereditary Angioedema Drug Sales Market Share in Value by Application (2024-2029)
Table 57. Global Hereditary Angioedema Drug Price by Application (2024-2029) & (USD/Unit)
Table 58. North America Hereditary Angioedema Drug Sales by Application (2018-2024) (K Units)
Table 59. North America Hereditary Angioedema Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Hereditary Angioedema Drug Sales by Application (2018-2024) (K Units)
Table 61. Europe Hereditary Angioedema Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Hereditary Angioedema Drug Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Hereditary Angioedema Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Hereditary Angioedema Drug Sales by Application (2018-2024) (K Units)
Table 65. Latin America Hereditary Angioedema Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Hereditary Angioedema Drug Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Hereditary Angioedema Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Hereditary Angioedema Drug Sales by Country (2018-2024) & (K Units)
Table 69. North America Hereditary Angioedema Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Hereditary Angioedema Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Hereditary Angioedema Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Hereditary Angioedema Drug Sales by Country (2024-2029) & (K Units)
Table 73. North America Hereditary Angioedema Drug Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Hereditary Angioedema Drug Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Hereditary Angioedema Drug Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Hereditary Angioedema Drug Sales by Country (2018-2024) & (K Units)
Table 77. Europe Hereditary Angioedema Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Hereditary Angioedema Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Hereditary Angioedema Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Hereditary Angioedema Drug Sales by Country (2024-2029) & (K Units)
Table 81. Europe Hereditary Angioedema Drug Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Hereditary Angioedema Drug Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Hereditary Angioedema Drug Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Hereditary Angioedema Drug Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Hereditary Angioedema Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Hereditary Angioedema Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Hereditary Angioedema Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Hereditary Angioedema Drug Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Hereditary Angioedema Drug Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Hereditary Angioedema Drug Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Hereditary Angioedema Drug Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Hereditary Angioedema Drug Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Hereditary Angioedema Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Hereditary Angioedema Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Hereditary Angioedema Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Hereditary Angioedema Drug Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Hereditary Angioedema Drug Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Hereditary Angioedema Drug Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Hereditary Angioedema Drug Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Hereditary Angioedema Drug Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Hereditary Angioedema Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Hereditary Angioedema Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Hereditary Angioedema Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Hereditary Angioedema Drug Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Hereditary Angioedema Drug Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Hereditary Angioedema Drug Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Hereditary Angioedema Drug Sales Market Share in Value by Country (2024-2029)
Table 108. Pharming Group NV Company Information
Table 109. Pharming Group NV Introduction and Business Overview
Table 110. Pharming Group NV Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Pharming Group NV Hereditary Angioedema Drug Product
Table 112. Pharming Group NV Recent Development
Table 113. Takeda Company Information
Table 114. Takeda Introduction and Business Overview
Table 115. Takeda Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Takeda Hereditary Angioedema Drug Product
Table 117. Takeda Recent Development
Table 118. CSL Limited Company Information
Table 119. CSL Limited Introduction and Business Overview
Table 120. CSL Limited Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. CSL Limited Hereditary Angioedema Drug Product
Table 122. CSL Limited Recent Development
Table 123. IBio Inc. Company Information
Table 124. IBio Inc. Introduction and Business Overview
Table 125. IBio Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. IBio Inc. Hereditary Angioedema Drug Product
Table 127. IBio Inc. Recent Development
Table 128. BioCryst Pharmaceuticals, Inc. Company Information
Table 129. BioCryst Pharmaceuticals, Inc. Introduction and Business Overview
Table 130. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product
Table 132. BioCryst Pharmaceuticals, Inc. Recent Development
Table 133. Ionis Pharmaceuticals, Inc. Company Information
Table 134. Ionis Pharmaceuticals, Inc. Introduction and Business Overview
Table 135. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product
Table 137. Ionis Pharmaceuticals, Inc. Recent Development
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Hereditary Angioedema Drug Market Trends
Table 141. Hereditary Angioedema Drug Market Drivers
Table 142. Hereditary Angioedema Drug Market Challenges
Table 143. Hereditary Angioedema Drug Market Restraints
Table 144. Hereditary Angioedema Drug Distributors List
Table 145. Hereditary Angioedema Drug Downstream Customers
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Hereditary Angioedema Drug Product Picture
Figure 2. Global Hereditary Angioedema Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Hereditary Angioedema Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Hereditary Angioedema Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of C1 Esterase Inhibitor
Figure 6. Global C1 Esterase Inhibitor Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Kallikrein Inhibitor
Figure 8. Global Kallikrein Inhibitor Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Selective Bradykinin B2 Receptor Antagonist
Figure 10. Global Selective Bradykinin B2 Receptor Antagonist Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Hereditary Angioedema Drug Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Hereditary Angioedema Drug Sales Market Share by Type in 2022 & 2029
Figure 13. North America Hereditary Angioedema Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Hereditary Angioedema Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Hereditary Angioedema Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Hereditary Angioedema Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Hereditary Angioedema Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Hereditary Angioedema Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Hereditary Angioedema Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Hereditary Angioedema Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Hereditary Angioedema Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Hereditary Angioedema Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Hereditary Angioedema Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Hereditary Angioedema Drug Revenue in 2022
Figure 25. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Retail Pharmacies
Figure 27. Global Retail Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Hospital Pharmacies
Figure 29. Global Hospital Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Online Pharmacies
Figure 31. Global Online Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Hereditary Angioedema Drug Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Hereditary Angioedema Drug Sales Market Share by Application in 2022 & 2029
Figure 34. North America Hereditary Angioedema Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Hereditary Angioedema Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Hereditary Angioedema Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Hereditary Angioedema Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Hereditary Angioedema Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Hereditary Angioedema Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Hereditary Angioedema Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Hereditary Angioedema Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Hereditary Angioedema Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Hereditary Angioedema Drug Manufacturing Cost Structure
Figure 45. Hereditary Angioedema Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries